nodes	percent_of_prediction	percent_of_DWPC	metapath
Everolimus—P-Glycoprotein Inhibitors—Cyclosporine—rheumatoid arthritis	0.32	0.521	CiPCiCtD
Everolimus—Cytochrome P450 3A4 Inhibitors—Cyclosporine—rheumatoid arthritis	0.294	0.479	CiPCiCtD
Everolimus—FKBP1A—Cyclosporine—rheumatoid arthritis	0.173	0.755	CbGbCtD
Everolimus—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0116	0.0505	CbGbCtD
Everolimus—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00853	0.0373	CbGbCtD
Everolimus—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00646	0.0282	CbGbCtD
Everolimus—CYP3A4—Betamethasone—rheumatoid arthritis	0.00554	0.0242	CbGbCtD
Everolimus—CYP3A4—Prednisolone—rheumatoid arthritis	0.00547	0.0239	CbGbCtD
Everolimus—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00519	0.0227	CbGbCtD
Everolimus—CYP3A4—Prednisone—rheumatoid arthritis	0.00517	0.0226	CbGbCtD
Everolimus—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0049	0.0214	CbGbCtD
Everolimus—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00323	0.0141	CbGbCtD
Everolimus—Hypertension—Betamethasone—rheumatoid arthritis	2.55e-05	0.000252	CcSEcCtD
Everolimus—Paraesthesia—Hydrocortisone—rheumatoid arthritis	2.54e-05	0.00025	CcSEcCtD
Everolimus—Myalgia—Dexamethasone—rheumatoid arthritis	2.52e-05	0.000248	CcSEcCtD
Everolimus—Myalgia—Betamethasone—rheumatoid arthritis	2.52e-05	0.000248	CcSEcCtD
Everolimus—Abdominal pain—Cyclosporine—rheumatoid arthritis	2.51e-05	0.000248	CcSEcCtD
Everolimus—Body temperature increased—Cyclosporine—rheumatoid arthritis	2.51e-05	0.000248	CcSEcCtD
Everolimus—Anxiety—Betamethasone—rheumatoid arthritis	2.51e-05	0.000247	CcSEcCtD
Everolimus—Anxiety—Dexamethasone—rheumatoid arthritis	2.51e-05	0.000247	CcSEcCtD
Everolimus—Discomfort—Dexamethasone—rheumatoid arthritis	2.49e-05	0.000245	CcSEcCtD
Everolimus—Discomfort—Betamethasone—rheumatoid arthritis	2.49e-05	0.000245	CcSEcCtD
Everolimus—Dyspepsia—Hydrocortisone—rheumatoid arthritis	2.49e-05	0.000245	CcSEcCtD
Everolimus—Haemoglobin—Methotrexate—rheumatoid arthritis	2.49e-05	0.000245	CcSEcCtD
Everolimus—Hypotension—Methylprednisolone—rheumatoid arthritis	2.48e-05	0.000244	CcSEcCtD
Everolimus—Pain—Prednisolone—rheumatoid arthritis	2.47e-05	0.000244	CcSEcCtD
Everolimus—Haemorrhage—Methotrexate—rheumatoid arthritis	2.47e-05	0.000244	CcSEcCtD
Everolimus—Hepatitis—Methotrexate—rheumatoid arthritis	2.47e-05	0.000244	CcSEcCtD
Everolimus—Decreased appetite—Hydrocortisone—rheumatoid arthritis	2.46e-05	0.000242	CcSEcCtD
Everolimus—Pharyngitis—Methotrexate—rheumatoid arthritis	2.45e-05	0.000242	CcSEcCtD
Everolimus—Nausea—Leflunomide—rheumatoid arthritis	2.45e-05	0.000241	CcSEcCtD
Everolimus—Urinary tract disorder—Methotrexate—rheumatoid arthritis	2.44e-05	0.000241	CcSEcCtD
Everolimus—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	2.44e-05	0.00024	CcSEcCtD
Everolimus—Fatigue—Hydrocortisone—rheumatoid arthritis	2.44e-05	0.00024	CcSEcCtD
Everolimus—Vision blurred—Prednisone—rheumatoid arthritis	2.43e-05	0.000239	CcSEcCtD
Everolimus—Urethral disorder—Methotrexate—rheumatoid arthritis	2.42e-05	0.000239	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	2.42e-05	0.000239	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	2.42e-05	0.000238	CcSEcCtD
Everolimus—Pain—Hydrocortisone—rheumatoid arthritis	2.42e-05	0.000238	CcSEcCtD
Everolimus—Oedema—Betamethasone—rheumatoid arthritis	2.41e-05	0.000238	CcSEcCtD
Everolimus—Oedema—Dexamethasone—rheumatoid arthritis	2.41e-05	0.000238	CcSEcCtD
Everolimus—Insomnia—Triamcinolone—rheumatoid arthritis	2.41e-05	0.000237	CcSEcCtD
Everolimus—Insomnia—Methylprednisolone—rheumatoid arthritis	2.4e-05	0.000237	CcSEcCtD
Everolimus—Infection—Dexamethasone—rheumatoid arthritis	2.4e-05	0.000236	CcSEcCtD
Everolimus—Infection—Betamethasone—rheumatoid arthritis	2.4e-05	0.000236	CcSEcCtD
Everolimus—Ill-defined disorder—Prednisone—rheumatoid arthritis	2.39e-05	0.000236	CcSEcCtD
Everolimus—Paraesthesia—Triamcinolone—rheumatoid arthritis	2.39e-05	0.000235	CcSEcCtD
Everolimus—Feeling abnormal—Prednisolone—rheumatoid arthritis	2.38e-05	0.000235	CcSEcCtD
Everolimus—Paraesthesia—Methylprednisolone—rheumatoid arthritis	2.38e-05	0.000235	CcSEcCtD
Everolimus—Anaemia—Prednisone—rheumatoid arthritis	2.38e-05	0.000235	CcSEcCtD
Everolimus—Shock—Betamethasone—rheumatoid arthritis	2.38e-05	0.000234	CcSEcCtD
Everolimus—Shock—Dexamethasone—rheumatoid arthritis	2.38e-05	0.000234	CcSEcCtD
Everolimus—Dyspnoea—Triamcinolone—rheumatoid arthritis	2.37e-05	0.000234	CcSEcCtD
Everolimus—Nervous system disorder—Dexamethasone—rheumatoid arthritis	2.37e-05	0.000233	CcSEcCtD
Everolimus—Nervous system disorder—Betamethasone—rheumatoid arthritis	2.37e-05	0.000233	CcSEcCtD
Everolimus—Agitation—Prednisone—rheumatoid arthritis	2.37e-05	0.000233	CcSEcCtD
Everolimus—Thrombocytopenia—Betamethasone—rheumatoid arthritis	2.36e-05	0.000233	CcSEcCtD
Everolimus—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	2.36e-05	0.000233	CcSEcCtD
Everolimus—Tachycardia—Dexamethasone—rheumatoid arthritis	2.36e-05	0.000232	CcSEcCtD
Everolimus—Tachycardia—Betamethasone—rheumatoid arthritis	2.36e-05	0.000232	CcSEcCtD
Everolimus—Angioedema—Prednisone—rheumatoid arthritis	2.35e-05	0.000232	CcSEcCtD
Everolimus—Hypersensitivity—Cyclosporine—rheumatoid arthritis	2.34e-05	0.000231	CcSEcCtD
Everolimus—Dyspepsia—Triamcinolone—rheumatoid arthritis	2.34e-05	0.000231	CcSEcCtD
Everolimus—Dyspepsia—Methylprednisolone—rheumatoid arthritis	2.34e-05	0.00023	CcSEcCtD
Everolimus—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	2.33e-05	0.00023	CcSEcCtD
Everolimus—Hyperhidrosis—Betamethasone—rheumatoid arthritis	2.33e-05	0.00023	CcSEcCtD
Everolimus—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	2.33e-05	0.000229	CcSEcCtD
Everolimus—Malaise—Prednisone—rheumatoid arthritis	2.32e-05	0.000229	CcSEcCtD
Everolimus—Eye disorder—Methotrexate—rheumatoid arthritis	2.31e-05	0.000228	CcSEcCtD
Everolimus—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	2.31e-05	0.000228	CcSEcCtD
Everolimus—Syncope—Prednisone—rheumatoid arthritis	2.31e-05	0.000228	CcSEcCtD
Everolimus—Anorexia—Dexamethasone—rheumatoid arthritis	2.3e-05	0.000227	CcSEcCtD
Everolimus—Anorexia—Betamethasone—rheumatoid arthritis	2.3e-05	0.000227	CcSEcCtD
Everolimus—Cardiac disorder—Methotrexate—rheumatoid arthritis	2.3e-05	0.000226	CcSEcCtD
Everolimus—Fatigue—Triamcinolone—rheumatoid arthritis	2.29e-05	0.000226	CcSEcCtD
Everolimus—Fatigue—Methylprednisolone—rheumatoid arthritis	2.29e-05	0.000226	CcSEcCtD
Everolimus—Asthenia—Cyclosporine—rheumatoid arthritis	2.28e-05	0.000225	CcSEcCtD
Everolimus—Pain—Triamcinolone—rheumatoid arthritis	2.28e-05	0.000224	CcSEcCtD
Everolimus—Loss of consciousness—Prednisone—rheumatoid arthritis	2.26e-05	0.000223	CcSEcCtD
Everolimus—Hypotension—Dexamethasone—rheumatoid arthritis	2.26e-05	0.000222	CcSEcCtD
Everolimus—Hypotension—Betamethasone—rheumatoid arthritis	2.26e-05	0.000222	CcSEcCtD
Everolimus—Pruritus—Cyclosporine—rheumatoid arthritis	2.25e-05	0.000222	CcSEcCtD
Everolimus—Angiopathy—Methotrexate—rheumatoid arthritis	2.24e-05	0.000221	CcSEcCtD
Everolimus—Immune system disorder—Methotrexate—rheumatoid arthritis	2.23e-05	0.00022	CcSEcCtD
Everolimus—Abdominal pain—Hydrocortisone—rheumatoid arthritis	2.23e-05	0.00022	CcSEcCtD
Everolimus—Body temperature increased—Hydrocortisone—rheumatoid arthritis	2.23e-05	0.00022	CcSEcCtD
Everolimus—Convulsion—Prednisone—rheumatoid arthritis	2.23e-05	0.00022	CcSEcCtD
Everolimus—Mediastinal disorder—Methotrexate—rheumatoid arthritis	2.23e-05	0.00022	CcSEcCtD
Everolimus—Hypertension—Prednisone—rheumatoid arthritis	2.22e-05	0.000219	CcSEcCtD
Everolimus—Chills—Methotrexate—rheumatoid arthritis	2.22e-05	0.000219	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	2.2e-05	0.000217	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	2.2e-05	0.000217	CcSEcCtD
Everolimus—Myalgia—Prednisone—rheumatoid arthritis	2.19e-05	0.000216	CcSEcCtD
Everolimus—Arthralgia—Prednisone—rheumatoid arthritis	2.19e-05	0.000216	CcSEcCtD
Everolimus—Feeling abnormal—Triamcinolone—rheumatoid arthritis	2.19e-05	0.000216	CcSEcCtD
Everolimus—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	2.19e-05	0.000216	CcSEcCtD
Everolimus—Anxiety—Prednisone—rheumatoid arthritis	2.19e-05	0.000215	CcSEcCtD
Everolimus—Alopecia—Methotrexate—rheumatoid arthritis	2.19e-05	0.000215	CcSEcCtD
Everolimus—Insomnia—Dexamethasone—rheumatoid arthritis	2.18e-05	0.000215	CcSEcCtD
Everolimus—Insomnia—Betamethasone—rheumatoid arthritis	2.18e-05	0.000215	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	2.18e-05	0.000215	CcSEcCtD
Everolimus—Diarrhoea—Cyclosporine—rheumatoid arthritis	2.18e-05	0.000214	CcSEcCtD
Everolimus—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	2.17e-05	0.000214	CcSEcCtD
Everolimus—Paraesthesia—Betamethasone—rheumatoid arthritis	2.17e-05	0.000214	CcSEcCtD
Everolimus—Paraesthesia—Dexamethasone—rheumatoid arthritis	2.17e-05	0.000214	CcSEcCtD
Everolimus—Discomfort—Prednisone—rheumatoid arthritis	2.17e-05	0.000214	CcSEcCtD
Everolimus—Mental disorder—Methotrexate—rheumatoid arthritis	2.17e-05	0.000214	CcSEcCtD
Everolimus—Malnutrition—Methotrexate—rheumatoid arthritis	2.15e-05	0.000212	CcSEcCtD
Everolimus—Erythema—Methotrexate—rheumatoid arthritis	2.15e-05	0.000212	CcSEcCtD
Everolimus—Hypersensitivity—Prednisolone—rheumatoid arthritis	2.13e-05	0.00021	CcSEcCtD
Everolimus—Dyspepsia—Betamethasone—rheumatoid arthritis	2.13e-05	0.000209	CcSEcCtD
Everolimus—Dyspepsia—Dexamethasone—rheumatoid arthritis	2.13e-05	0.000209	CcSEcCtD
Everolimus—Dysgeusia—Methotrexate—rheumatoid arthritis	2.11e-05	0.000208	CcSEcCtD
Everolimus—Body temperature increased—Triamcinolone—rheumatoid arthritis	2.1e-05	0.000207	CcSEcCtD
Everolimus—Dizziness—Cyclosporine—rheumatoid arthritis	2.1e-05	0.000207	CcSEcCtD
Everolimus—Oedema—Prednisone—rheumatoid arthritis	2.1e-05	0.000207	CcSEcCtD
Everolimus—Abdominal pain—Methylprednisolone—rheumatoid arthritis	2.1e-05	0.000207	CcSEcCtD
Everolimus—Decreased appetite—Dexamethasone—rheumatoid arthritis	2.1e-05	0.000207	CcSEcCtD
Everolimus—Decreased appetite—Betamethasone—rheumatoid arthritis	2.1e-05	0.000207	CcSEcCtD
Everolimus—Infection—Prednisone—rheumatoid arthritis	2.09e-05	0.000206	CcSEcCtD
Everolimus—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	2.08e-05	0.000205	CcSEcCtD
Everolimus—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	2.08e-05	0.000205	CcSEcCtD
Everolimus—Back pain—Methotrexate—rheumatoid arthritis	2.08e-05	0.000205	CcSEcCtD
Everolimus—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	2.08e-05	0.000205	CcSEcCtD
Everolimus—Fatigue—Betamethasone—rheumatoid arthritis	2.08e-05	0.000205	CcSEcCtD
Everolimus—Fatigue—Dexamethasone—rheumatoid arthritis	2.08e-05	0.000205	CcSEcCtD
Everolimus—Shock—Prednisone—rheumatoid arthritis	2.07e-05	0.000204	CcSEcCtD
Everolimus—Pain—Dexamethasone—rheumatoid arthritis	2.06e-05	0.000203	CcSEcCtD
Everolimus—Pain—Betamethasone—rheumatoid arthritis	2.06e-05	0.000203	CcSEcCtD
Everolimus—Nervous system disorder—Prednisone—rheumatoid arthritis	2.06e-05	0.000203	CcSEcCtD
Everolimus—Tachycardia—Prednisone—rheumatoid arthritis	2.05e-05	0.000202	CcSEcCtD
Everolimus—Skin disorder—Prednisone—rheumatoid arthritis	2.04e-05	0.000201	CcSEcCtD
Everolimus—Hyperhidrosis—Prednisone—rheumatoid arthritis	2.03e-05	0.0002	CcSEcCtD
Everolimus—Vision blurred—Methotrexate—rheumatoid arthritis	2.03e-05	0.0002	CcSEcCtD
Everolimus—Asthenia—Hydrocortisone—rheumatoid arthritis	2.03e-05	0.0002	CcSEcCtD
Everolimus—Vomiting—Cyclosporine—rheumatoid arthritis	2.02e-05	0.000199	CcSEcCtD
Everolimus—Rash—Cyclosporine—rheumatoid arthritis	2.01e-05	0.000198	CcSEcCtD
Everolimus—Anorexia—Prednisone—rheumatoid arthritis	2e-05	0.000198	CcSEcCtD
Everolimus—Dermatitis—Cyclosporine—rheumatoid arthritis	2e-05	0.000197	CcSEcCtD
Everolimus—Pruritus—Hydrocortisone—rheumatoid arthritis	2e-05	0.000197	CcSEcCtD
Everolimus—Ill-defined disorder—Methotrexate—rheumatoid arthritis	2e-05	0.000197	CcSEcCtD
Everolimus—Headache—Cyclosporine—rheumatoid arthritis	1.99e-05	0.000196	CcSEcCtD
Everolimus—Anaemia—Methotrexate—rheumatoid arthritis	1.99e-05	0.000196	CcSEcCtD
Everolimus—Feeling abnormal—Dexamethasone—rheumatoid arthritis	1.99e-05	0.000196	CcSEcCtD
Everolimus—Feeling abnormal—Betamethasone—rheumatoid arthritis	1.99e-05	0.000196	CcSEcCtD
Everolimus—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	1.97e-05	0.000195	CcSEcCtD
Everolimus—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	1.97e-05	0.000195	CcSEcCtD
Everolimus—Hypersensitivity—Triamcinolone—rheumatoid arthritis	1.96e-05	0.000193	CcSEcCtD
Everolimus—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	1.96e-05	0.000193	CcSEcCtD
Everolimus—Malaise—Methotrexate—rheumatoid arthritis	1.94e-05	0.000191	CcSEcCtD
Everolimus—Diarrhoea—Hydrocortisone—rheumatoid arthritis	1.93e-05	0.000191	CcSEcCtD
Everolimus—Leukopenia—Methotrexate—rheumatoid arthritis	1.93e-05	0.00019	CcSEcCtD
Everolimus—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	1.92e-05	0.000189	CcSEcCtD
Everolimus—Dizziness—Prednisolone—rheumatoid arthritis	1.91e-05	0.000189	CcSEcCtD
Everolimus—Asthenia—Triamcinolone—rheumatoid arthritis	1.91e-05	0.000188	CcSEcCtD
Everolimus—Body temperature increased—Dexamethasone—rheumatoid arthritis	1.91e-05	0.000188	CcSEcCtD
Everolimus—Abdominal pain—Betamethasone—rheumatoid arthritis	1.91e-05	0.000188	CcSEcCtD
Everolimus—Body temperature increased—Betamethasone—rheumatoid arthritis	1.91e-05	0.000188	CcSEcCtD
Everolimus—Abdominal pain—Dexamethasone—rheumatoid arthritis	1.91e-05	0.000188	CcSEcCtD
Everolimus—Asthenia—Methylprednisolone—rheumatoid arthritis	1.91e-05	0.000188	CcSEcCtD
Everolimus—Insomnia—Prednisone—rheumatoid arthritis	1.9e-05	0.000187	CcSEcCtD
Everolimus—MTOR—Signaling Pathways—PLB1—rheumatoid arthritis	1.9e-05	0.00034	CbGpPWpGaD
Everolimus—Nausea—Cyclosporine—rheumatoid arthritis	1.89e-05	0.000186	CcSEcCtD
Everolimus—Paraesthesia—Prednisone—rheumatoid arthritis	1.89e-05	0.000186	CcSEcCtD
Everolimus—Pruritus—Triamcinolone—rheumatoid arthritis	1.88e-05	0.000186	CcSEcCtD
Everolimus—Cough—Methotrexate—rheumatoid arthritis	1.88e-05	0.000185	CcSEcCtD
Everolimus—Pruritus—Methylprednisolone—rheumatoid arthritis	1.88e-05	0.000185	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—NCF1—rheumatoid arthritis	1.87e-05	0.000336	CbGpPWpGaD
Everolimus—Dizziness—Hydrocortisone—rheumatoid arthritis	1.87e-05	0.000184	CcSEcCtD
Everolimus—Convulsion—Methotrexate—rheumatoid arthritis	1.87e-05	0.000184	CcSEcCtD
Everolimus—MTOR—Immune System—IRF8—rheumatoid arthritis	1.86e-05	0.000334	CbGpPWpGaD
Everolimus—MTOR—Immune System—ITGAM—rheumatoid arthritis	1.86e-05	0.000334	CbGpPWpGaD
Everolimus—MTOR—Immune System—CCR6—rheumatoid arthritis	1.86e-05	0.000334	CbGpPWpGaD
Everolimus—Dyspepsia—Prednisone—rheumatoid arthritis	1.85e-05	0.000182	CcSEcCtD
Everolimus—MTOR—Integrated Breast Cancer Pathway—TP53—rheumatoid arthritis	1.85e-05	0.000331	CbGpPWpGaD
Everolimus—Myalgia—Methotrexate—rheumatoid arthritis	1.83e-05	0.000181	CcSEcCtD
Everolimus—Arthralgia—Methotrexate—rheumatoid arthritis	1.83e-05	0.000181	CcSEcCtD
Everolimus—Chest pain—Methotrexate—rheumatoid arthritis	1.83e-05	0.000181	CcSEcCtD
Everolimus—Decreased appetite—Prednisone—rheumatoid arthritis	1.83e-05	0.00018	CcSEcCtD
Everolimus—Rash—Prednisolone—rheumatoid arthritis	1.82e-05	0.00018	CcSEcCtD
Everolimus—Dermatitis—Prednisolone—rheumatoid arthritis	1.82e-05	0.00018	CcSEcCtD
Everolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	1.82e-05	0.000179	CcSEcCtD
Everolimus—Diarrhoea—Methylprednisolone—rheumatoid arthritis	1.82e-05	0.000179	CcSEcCtD
Everolimus—MTOR—Innate Immune System—AGER—rheumatoid arthritis	1.82e-05	0.000326	CbGpPWpGaD
Everolimus—MTOR—Disease—SLC11A1—rheumatoid arthritis	1.81e-05	0.000325	CbGpPWpGaD
Everolimus—Fatigue—Prednisone—rheumatoid arthritis	1.81e-05	0.000179	CcSEcCtD
Everolimus—Headache—Prednisolone—rheumatoid arthritis	1.81e-05	0.000179	CcSEcCtD
Everolimus—Discomfort—Methotrexate—rheumatoid arthritis	1.81e-05	0.000178	CcSEcCtD
Everolimus—MTOR—Immune System—NCF2—rheumatoid arthritis	1.81e-05	0.000325	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD40LG—rheumatoid arthritis	1.81e-05	0.000324	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CD28—rheumatoid arthritis	1.8e-05	0.000323	CbGpPWpGaD
Everolimus—MTOR—Disease—NFATC1—rheumatoid arthritis	1.8e-05	0.000322	CbGpPWpGaD
Everolimus—Constipation—Prednisone—rheumatoid arthritis	1.8e-05	0.000177	CcSEcCtD
Everolimus—Vomiting—Hydrocortisone—rheumatoid arthritis	1.8e-05	0.000177	CcSEcCtD
Everolimus—MTOR—Innate Immune System—HLA-B—rheumatoid arthritis	1.79e-05	0.000321	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD8A—rheumatoid arthritis	1.79e-05	0.000321	CbGpPWpGaD
Everolimus—MTOR—Signaling by SCF-KIT—IL6—rheumatoid arthritis	1.79e-05	0.00032	CbGpPWpGaD
Everolimus—Rash—Hydrocortisone—rheumatoid arthritis	1.78e-05	0.000176	CcSEcCtD
Everolimus—Dermatitis—Hydrocortisone—rheumatoid arthritis	1.78e-05	0.000175	CcSEcCtD
Everolimus—MTOR—Immune System—FCGR2A—rheumatoid arthritis	1.78e-05	0.000318	CbGpPWpGaD
Everolimus—Headache—Hydrocortisone—rheumatoid arthritis	1.77e-05	0.000174	CcSEcCtD
Everolimus—MTOR—Immune System—TRAF6—rheumatoid arthritis	1.76e-05	0.000316	CbGpPWpGaD
Everolimus—Dizziness—Triamcinolone—rheumatoid arthritis	1.76e-05	0.000173	CcSEcCtD
Everolimus—Dizziness—Methylprednisolone—rheumatoid arthritis	1.76e-05	0.000173	CcSEcCtD
Everolimus—CYP3A4—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	1.75e-05	0.000314	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RBPJ—rheumatoid arthritis	1.75e-05	0.000313	CbGpPWpGaD
Everolimus—Infection—Methotrexate—rheumatoid arthritis	1.75e-05	0.000172	CcSEcCtD
Everolimus—MTOR—Immune System—TNFAIP3—rheumatoid arthritis	1.74e-05	0.000312	CbGpPWpGaD
Everolimus—Feeling abnormal—Prednisone—rheumatoid arthritis	1.73e-05	0.000171	CcSEcCtD
Everolimus—Asthenia—Betamethasone—rheumatoid arthritis	1.73e-05	0.000171	CcSEcCtD
Everolimus—Asthenia—Dexamethasone—rheumatoid arthritis	1.73e-05	0.000171	CcSEcCtD
Everolimus—Nervous system disorder—Methotrexate—rheumatoid arthritis	1.72e-05	0.00017	CcSEcCtD
Everolimus—MTOR—Cellular responses to stress—NFKB1—rheumatoid arthritis	1.72e-05	0.000309	CbGpPWpGaD
Everolimus—MTOR—Immune System—BLK—rheumatoid arthritis	1.72e-05	0.000309	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-B—rheumatoid arthritis	1.72e-05	0.000308	CbGpPWpGaD
Everolimus—Thrombocytopenia—Methotrexate—rheumatoid arthritis	1.72e-05	0.00017	CcSEcCtD
Everolimus—Gastrointestinal pain—Prednisone—rheumatoid arthritis	1.72e-05	0.000169	CcSEcCtD
Everolimus—Nausea—Prednisolone—rheumatoid arthritis	1.72e-05	0.000169	CcSEcCtD
Everolimus—MTOR—Downstream signaling of activated FGFR—IL6—rheumatoid arthritis	1.71e-05	0.000306	CbGpPWpGaD
Everolimus—Pruritus—Dexamethasone—rheumatoid arthritis	1.71e-05	0.000168	CcSEcCtD
Everolimus—Pruritus—Betamethasone—rheumatoid arthritis	1.71e-05	0.000168	CcSEcCtD
Everolimus—Skin disorder—Methotrexate—rheumatoid arthritis	1.71e-05	0.000168	CcSEcCtD
Everolimus—MTOR—Immune System—PTPN2—rheumatoid arthritis	1.7e-05	0.000305	CbGpPWpGaD
Everolimus—Hyperhidrosis—Methotrexate—rheumatoid arthritis	1.7e-05	0.000167	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—UBE2D1—rheumatoid arthritis	1.7e-05	0.000304	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—MAPK8—rheumatoid arthritis	1.69e-05	0.000304	CbGpPWpGaD
Everolimus—Vomiting—Triamcinolone—rheumatoid arthritis	1.69e-05	0.000167	CcSEcCtD
Everolimus—Vomiting—Methylprednisolone—rheumatoid arthritis	1.69e-05	0.000166	CcSEcCtD
Everolimus—MTOR—Signaling by ERBB4—IL6—rheumatoid arthritis	1.68e-05	0.000301	CbGpPWpGaD
Everolimus—Nausea—Hydrocortisone—rheumatoid arthritis	1.68e-05	0.000165	CcSEcCtD
Everolimus—Rash—Triamcinolone—rheumatoid arthritis	1.68e-05	0.000165	CcSEcCtD
Everolimus—Dermatitis—Triamcinolone—rheumatoid arthritis	1.68e-05	0.000165	CcSEcCtD
Everolimus—Anorexia—Methotrexate—rheumatoid arthritis	1.68e-05	0.000165	CcSEcCtD
Everolimus—Rash—Methylprednisolone—rheumatoid arthritis	1.67e-05	0.000165	CcSEcCtD
Everolimus—Dermatitis—Methylprednisolone—rheumatoid arthritis	1.67e-05	0.000165	CcSEcCtD
Everolimus—MTOR—Disease—NCF2—rheumatoid arthritis	1.67e-05	0.0003	CbGpPWpGaD
Everolimus—Headache—Triamcinolone—rheumatoid arthritis	1.67e-05	0.000164	CcSEcCtD
Everolimus—MTOR—Immune System—SAA1—rheumatoid arthritis	1.67e-05	0.000298	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—C3—rheumatoid arthritis	1.66e-05	0.000298	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CXCL12—rheumatoid arthritis	1.66e-05	0.000298	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—BDKRB2—rheumatoid arthritis	1.66e-05	0.000298	CbGpPWpGaD
Everolimus—Headache—Methylprednisolone—rheumatoid arthritis	1.66e-05	0.000164	CcSEcCtD
Everolimus—Abdominal pain—Prednisone—rheumatoid arthritis	1.66e-05	0.000164	CcSEcCtD
Everolimus—Body temperature increased—Prednisone—rheumatoid arthritis	1.66e-05	0.000164	CcSEcCtD
Everolimus—Diarrhoea—Betamethasone—rheumatoid arthritis	1.65e-05	0.000163	CcSEcCtD
Everolimus—Diarrhoea—Dexamethasone—rheumatoid arthritis	1.65e-05	0.000163	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—ADRBK1—rheumatoid arthritis	1.65e-05	0.000295	CbGpPWpGaD
Everolimus—Hypotension—Methotrexate—rheumatoid arthritis	1.64e-05	0.000162	CcSEcCtD
Everolimus—MTOR—Immune System—NCF1—rheumatoid arthritis	1.63e-05	0.000292	CbGpPWpGaD
Everolimus—MTOR—Immune System—CTSD—rheumatoid arthritis	1.63e-05	0.000292	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CCR5—rheumatoid arthritis	1.63e-05	0.000292	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—NFKB1—rheumatoid arthritis	1.62e-05	0.00029	CbGpPWpGaD
Everolimus—MTOR—Downstream signal transduction—IL6—rheumatoid arthritis	1.61e-05	0.000288	CbGpPWpGaD
Everolimus—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	1.6e-05	0.000158	CcSEcCtD
Everolimus—MTOR—Adaptive Immune System—C3—rheumatoid arthritis	1.6e-05	0.000287	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR—IL6—rheumatoid arthritis	1.6e-05	0.000286	CbGpPWpGaD
Everolimus—Dizziness—Dexamethasone—rheumatoid arthritis	1.6e-05	0.000157	CcSEcCtD
Everolimus—Dizziness—Betamethasone—rheumatoid arthritis	1.6e-05	0.000157	CcSEcCtD
Everolimus—MTOR—Adaptive Immune System—HLA-A—rheumatoid arthritis	1.59e-05	0.000286	CbGpPWpGaD
Everolimus—FKBP1A—Disease—MTHFR—rheumatoid arthritis	1.59e-05	0.000285	CbGpPWpGaD
Everolimus—MTOR—Signaling by ERBB2—IL6—rheumatoid arthritis	1.59e-05	0.000285	CbGpPWpGaD
Everolimus—Insomnia—Methotrexate—rheumatoid arthritis	1.59e-05	0.000157	CcSEcCtD
Everolimus—MTOR—Signaling by NGF—MAPK8—rheumatoid arthritis	1.59e-05	0.000285	CbGpPWpGaD
Everolimus—FKBP1A—Disease—HLA-A—rheumatoid arthritis	1.59e-05	0.000284	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CRP—rheumatoid arthritis	1.58e-05	0.000284	CbGpPWpGaD
Everolimus—MTOR—DAP12 signaling—IL6—rheumatoid arthritis	1.58e-05	0.000284	CbGpPWpGaD
Everolimus—Nausea—Triamcinolone—rheumatoid arthritis	1.58e-05	0.000156	CcSEcCtD
Everolimus—Paraesthesia—Methotrexate—rheumatoid arthritis	1.58e-05	0.000156	CcSEcCtD
Everolimus—Nausea—Methylprednisolone—rheumatoid arthritis	1.58e-05	0.000155	CcSEcCtD
Everolimus—MTOR—Immune System—CD28—rheumatoid arthritis	1.57e-05	0.000281	CbGpPWpGaD
Everolimus—Dyspnoea—Methotrexate—rheumatoid arthritis	1.57e-05	0.000154	CcSEcCtD
Everolimus—MTOR—Cellular responses to stress—VEGFA—rheumatoid arthritis	1.56e-05	0.00028	CbGpPWpGaD
Everolimus—Somnolence—Methotrexate—rheumatoid arthritis	1.56e-05	0.000154	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—RASGRP1—rheumatoid arthritis	1.55e-05	0.000278	CbGpPWpGaD
Everolimus—Hypersensitivity—Prednisone—rheumatoid arthritis	1.55e-05	0.000153	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—SYK—rheumatoid arthritis	1.55e-05	0.000277	CbGpPWpGaD
Everolimus—Dyspepsia—Methotrexate—rheumatoid arthritis	1.55e-05	0.000152	CcSEcCtD
Everolimus—MTOR—Signaling Pathways—CXCL13—rheumatoid arthritis	1.54e-05	0.000277	CbGpPWpGaD
Everolimus—MTOR—Immune System—PTPRC—rheumatoid arthritis	1.54e-05	0.000276	CbGpPWpGaD
Everolimus—MTOR—Disease—SAA1—rheumatoid arthritis	1.54e-05	0.000276	CbGpPWpGaD
Everolimus—Vomiting—Betamethasone—rheumatoid arthritis	1.54e-05	0.000151	CcSEcCtD
Everolimus—Vomiting—Dexamethasone—rheumatoid arthritis	1.54e-05	0.000151	CcSEcCtD
Everolimus—MTOR—Immune System—IL1RN—rheumatoid arthritis	1.53e-05	0.000275	CbGpPWpGaD
Everolimus—Decreased appetite—Methotrexate—rheumatoid arthritis	1.53e-05	0.000151	CcSEcCtD
Everolimus—Rash—Betamethasone—rheumatoid arthritis	1.52e-05	0.00015	CcSEcCtD
Everolimus—Rash—Dexamethasone—rheumatoid arthritis	1.52e-05	0.00015	CcSEcCtD
Everolimus—Dermatitis—Betamethasone—rheumatoid arthritis	1.52e-05	0.00015	CcSEcCtD
Everolimus—Dermatitis—Dexamethasone—rheumatoid arthritis	1.52e-05	0.00015	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—PRKCQ—rheumatoid arthritis	1.52e-05	0.000272	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—TLR4—rheumatoid arthritis	1.52e-05	0.000272	CbGpPWpGaD
Everolimus—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	1.52e-05	0.00015	CcSEcCtD
Everolimus—Fatigue—Methotrexate—rheumatoid arthritis	1.52e-05	0.000149	CcSEcCtD
Everolimus—Headache—Dexamethasone—rheumatoid arthritis	1.51e-05	0.000149	CcSEcCtD
Everolimus—Headache—Betamethasone—rheumatoid arthritis	1.51e-05	0.000149	CcSEcCtD
Everolimus—Asthenia—Prednisone—rheumatoid arthritis	1.51e-05	0.000149	CcSEcCtD
Everolimus—MTOR—Disease—NCF1—rheumatoid arthritis	1.51e-05	0.00027	CbGpPWpGaD
Everolimus—Pain—Methotrexate—rheumatoid arthritis	1.5e-05	0.000148	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—STAT1—rheumatoid arthritis	1.49e-05	0.000267	CbGpPWpGaD
Everolimus—MTOR—Disease—ENO1—rheumatoid arthritis	1.49e-05	0.000267	CbGpPWpGaD
Everolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—rheumatoid arthritis	1.49e-05	0.000267	CbGpPWpGaD
Everolimus—MTOR—Signaling by FGFR in disease—IL6—rheumatoid arthritis	1.49e-05	0.000267	CbGpPWpGaD
Everolimus—MTOR—DAP12 interactions—IL6—rheumatoid arthritis	1.49e-05	0.000267	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-DPB1—rheumatoid arthritis	1.49e-05	0.000267	CbGpPWpGaD
Everolimus—Pruritus—Prednisone—rheumatoid arthritis	1.49e-05	0.000147	CcSEcCtD
Everolimus—MTOR—Immune System—UBE2D1—rheumatoid arthritis	1.48e-05	0.000265	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR—IL6—rheumatoid arthritis	1.48e-05	0.000264	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CXCL10—rheumatoid arthritis	1.47e-05	0.000264	CbGpPWpGaD
Everolimus—MTOR—Signaling by EGFR in Cancer—IL6—rheumatoid arthritis	1.46e-05	0.000262	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—HLA-DRB1—rheumatoid arthritis	1.46e-05	0.000261	CbGpPWpGaD
Everolimus—MTOR—Signaling by PDGF—IL6—rheumatoid arthritis	1.46e-05	0.000261	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—IL6ST—rheumatoid arthritis	1.46e-05	0.000261	CbGpPWpGaD
Everolimus—Feeling abnormal—Methotrexate—rheumatoid arthritis	1.45e-05	0.000143	CcSEcCtD
Everolimus—MTOR—Disease—CD28—rheumatoid arthritis	1.45e-05	0.000259	CbGpPWpGaD
Everolimus—Diarrhoea—Prednisone—rheumatoid arthritis	1.44e-05	0.000142	CcSEcCtD
Everolimus—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	1.44e-05	0.000142	CcSEcCtD
Everolimus—Nausea—Betamethasone—rheumatoid arthritis	1.43e-05	0.000141	CcSEcCtD
Everolimus—Nausea—Dexamethasone—rheumatoid arthritis	1.43e-05	0.000141	CcSEcCtD
Everolimus—MTOR—Immune System—CD40—rheumatoid arthritis	1.43e-05	0.000257	CbGpPWpGaD
Everolimus—MTOR—Immune System—ADRBK1—rheumatoid arthritis	1.43e-05	0.000257	CbGpPWpGaD
Everolimus—MTOR—Immune System—HMGB1—rheumatoid arthritis	1.41e-05	0.000253	CbGpPWpGaD
Everolimus—MTOR—Immune System—CTLA4—rheumatoid arthritis	1.41e-05	0.000253	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CD80—rheumatoid arthritis	1.4e-05	0.000251	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—ICAM1—rheumatoid arthritis	1.4e-05	0.000251	CbGpPWpGaD
Everolimus—FKBP1A—Disease—IL6ST—rheumatoid arthritis	1.39e-05	0.000249	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IRAK1—rheumatoid arthritis	1.39e-05	0.000249	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TLE3—rheumatoid arthritis	1.39e-05	0.000249	CbGpPWpGaD
Everolimus—Dizziness—Prednisone—rheumatoid arthritis	1.39e-05	0.000137	CcSEcCtD
Everolimus—Body temperature increased—Methotrexate—rheumatoid arthritis	1.39e-05	0.000137	CcSEcCtD
Everolimus—Abdominal pain—Methotrexate—rheumatoid arthritis	1.39e-05	0.000137	CcSEcCtD
Everolimus—FKBP1A—Disease—NOS2—rheumatoid arthritis	1.38e-05	0.000247	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CX3CR1—rheumatoid arthritis	1.38e-05	0.000247	CbGpPWpGaD
Everolimus—MTOR—Disease—UBE2D1—rheumatoid arthritis	1.36e-05	0.000244	CbGpPWpGaD
Everolimus—MTOR—Immune System—RASGRP1—rheumatoid arthritis	1.35e-05	0.000242	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD79A—rheumatoid arthritis	1.35e-05	0.000241	CbGpPWpGaD
Everolimus—MTOR—Immune System—SYK—rheumatoid arthritis	1.35e-05	0.000241	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD80—rheumatoid arthritis	1.35e-05	0.000241	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MMP3—rheumatoid arthritis	1.34e-05	0.00024	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CD80—rheumatoid arthritis	1.34e-05	0.00024	CbGpPWpGaD
Everolimus—Vomiting—Prednisone—rheumatoid arthritis	1.34e-05	0.000132	CcSEcCtD
Everolimus—Rash—Prednisone—rheumatoid arthritis	1.33e-05	0.000131	CcSEcCtD
Everolimus—MTOR—Signaling Pathways—IL2RB—rheumatoid arthritis	1.33e-05	0.000238	CbGpPWpGaD
Everolimus—Dermatitis—Prednisone—rheumatoid arthritis	1.32e-05	0.000131	CcSEcCtD
Everolimus—MTOR—Disease—ADRBK1—rheumatoid arthritis	1.32e-05	0.000237	CbGpPWpGaD
Everolimus—MTOR—Immune System—PRKCQ—rheumatoid arthritis	1.32e-05	0.000237	CbGpPWpGaD
Everolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—rheumatoid arthritis	1.32e-05	0.000236	CbGpPWpGaD
Everolimus—Headache—Prednisone—rheumatoid arthritis	1.32e-05	0.00013	CcSEcCtD
Everolimus—MTOR—Innate Immune System—IL6R—rheumatoid arthritis	1.3e-05	0.000233	CbGpPWpGaD
Everolimus—MTOR—Immune System—STAT1—rheumatoid arthritis	1.3e-05	0.000233	CbGpPWpGaD
Everolimus—Hypersensitivity—Methotrexate—rheumatoid arthritis	1.29e-05	0.000128	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—PTK2—rheumatoid arthritis	1.29e-05	0.000231	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—C5—rheumatoid arthritis	1.28e-05	0.000229	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCL5—rheumatoid arthritis	1.27e-05	0.000227	CbGpPWpGaD
Everolimus—Asthenia—Methotrexate—rheumatoid arthritis	1.26e-05	0.000124	CcSEcCtD
Everolimus—MTOR—Signaling Pathways—NFATC1—rheumatoid arthritis	1.26e-05	0.000226	CbGpPWpGaD
Everolimus—Nausea—Prednisone—rheumatoid arthritis	1.25e-05	0.000123	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—CSF2—rheumatoid arthritis	1.25e-05	0.000224	CbGpPWpGaD
Everolimus—MTOR—Immune System—VCAM1—rheumatoid arthritis	1.25e-05	0.000223	CbGpPWpGaD
Everolimus—Pruritus—Methotrexate—rheumatoid arthritis	1.24e-05	0.000123	CcSEcCtD
Everolimus—MTOR—Immune System—HLA-DQA1—rheumatoid arthritis	1.24e-05	0.000223	CbGpPWpGaD
Everolimus—FKBP1A—Disease—IL6R—rheumatoid arthritis	1.24e-05	0.000223	CbGpPWpGaD
Everolimus—MTOR—Disease—PRKCQ—rheumatoid arthritis	1.22e-05	0.000219	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCR6—rheumatoid arthritis	1.2e-05	0.000216	CbGpPWpGaD
Everolimus—Diarrhoea—Methotrexate—rheumatoid arthritis	1.2e-05	0.000118	CcSEcCtD
Everolimus—MTOR—Disease—STAT1—rheumatoid arthritis	1.2e-05	0.000215	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—TYK2—rheumatoid arthritis	1.18e-05	0.000212	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—TP53—rheumatoid arthritis	1.18e-05	0.000212	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—SPP1—rheumatoid arthritis	1.17e-05	0.00021	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NCF2—rheumatoid arthritis	1.17e-05	0.00021	CbGpPWpGaD
Everolimus—Dizziness—Methotrexate—rheumatoid arthritis	1.16e-05	0.000115	CcSEcCtD
Everolimus—MTOR—Immune System—HLA-DQB1—rheumatoid arthritis	1.16e-05	0.000208	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SH2B3—rheumatoid arthritis	1.14e-05	0.000204	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TRAF6—rheumatoid arthritis	1.14e-05	0.000204	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCR5—rheumatoid arthritis	1.14e-05	0.000204	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—GZMB—rheumatoid arthritis	1.13e-05	0.000203	CbGpPWpGaD
Everolimus—FKBP1A—Disease—TYK2—rheumatoid arthritis	1.13e-05	0.000203	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL2RA—rheumatoid arthritis	1.12e-05	0.000201	CbGpPWpGaD
Everolimus—MTOR—Immune System—PTK2—rheumatoid arthritis	1.12e-05	0.000201	CbGpPWpGaD
Everolimus—Vomiting—Methotrexate—rheumatoid arthritis	1.12e-05	0.00011	CcSEcCtD
Everolimus—FKBP1A—Signaling Pathways—C3—rheumatoid arthritis	1.11e-05	0.0002	CbGpPWpGaD
Everolimus—FKBP1A—Disease—NOS3—rheumatoid arthritis	1.11e-05	0.000199	CbGpPWpGaD
Everolimus—Rash—Methotrexate—rheumatoid arthritis	1.11e-05	0.000109	CcSEcCtD
Everolimus—Dermatitis—Methotrexate—rheumatoid arthritis	1.11e-05	0.000109	CcSEcCtD
Everolimus—MTOR—Immune System—IL1A—rheumatoid arthritis	1.1e-05	0.000198	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL18—rheumatoid arthritis	1.1e-05	0.000197	CbGpPWpGaD
Everolimus—Headache—Methotrexate—rheumatoid arthritis	1.1e-05	0.000108	CcSEcCtD
Everolimus—MTOR—Signaling Pathways—CXCL2—rheumatoid arthritis	1.1e-05	0.000197	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCL3—rheumatoid arthritis	1.1e-05	0.000197	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—FADS2—rheumatoid arthritis	1.1e-05	0.000197	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD40LG—rheumatoid arthritis	1.1e-05	0.000197	CbGpPWpGaD
Everolimus—MTOR—Immune System—CSF2—rheumatoid arthritis	1.08e-05	0.000194	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD8A—rheumatoid arthritis	1.08e-05	0.000194	CbGpPWpGaD
Everolimus—MTOR—Cellular responses to stress—IL6—rheumatoid arthritis	1.08e-05	0.000194	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SAA1—rheumatoid arthritis	1.08e-05	0.000193	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—CD4—rheumatoid arthritis	1.07e-05	0.000192	CbGpPWpGaD
Everolimus—MTOR—Immune System—AGER—rheumatoid arthritis	1.06e-05	0.00019	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NCF1—rheumatoid arthritis	1.05e-05	0.000189	CbGpPWpGaD
Everolimus—Nausea—Methotrexate—rheumatoid arthritis	1.04e-05	0.000103	CcSEcCtD
Everolimus—MTOR—Immune System—HLA-B—rheumatoid arthritis	1.04e-05	0.000187	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—LEP—rheumatoid arthritis	1.04e-05	0.000186	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—CD4—rheumatoid arthritis	1.03e-05	0.000184	CbGpPWpGaD
Everolimus—FKBP1A—Disease—CD4—rheumatoid arthritis	1.02e-05	0.000183	CbGpPWpGaD
Everolimus—FKBP1A—Disease—PTGS2—rheumatoid arthritis	1.02e-05	0.000182	CbGpPWpGaD
Everolimus—MTOR—Signaling by NGF—IL6—rheumatoid arthritis	1.01e-05	0.000182	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CD28—rheumatoid arthritis	1.01e-05	0.000182	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—FN1—rheumatoid arthritis	9.79e-06	0.000175	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL2RA—rheumatoid arthritis	9.78e-06	0.000175	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL6ST—rheumatoid arthritis	9.75e-06	0.000175	CbGpPWpGaD
Everolimus—MTOR—Immune System—C3—rheumatoid arthritis	9.7e-06	0.000174	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-A—rheumatoid arthritis	9.67e-06	0.000173	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—UBE2D1—rheumatoid arthritis	9.54e-06	0.000171	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CD80—rheumatoid arthritis	9.38e-06	0.000168	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—BDKRB2—rheumatoid arthritis	9.36e-06	0.000168	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CXCL12—rheumatoid arthritis	9.36e-06	0.000168	CbGpPWpGaD
Everolimus—CYP3A4—Biological oxidations—POMC—rheumatoid arthritis	9.3e-06	0.000167	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—ADRBK1—rheumatoid arthritis	9.26e-06	0.000166	CbGpPWpGaD
Everolimus—MTOR—Immune System—CRP—rheumatoid arthritis	9.22e-06	0.000165	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—NFKB1—rheumatoid arthritis	9.22e-06	0.000165	CbGpPWpGaD
Everolimus—MTOR—Disease—CCR5—rheumatoid arthritis	9.16e-06	0.000164	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—MAPK8—rheumatoid arthritis	9.06e-06	0.000162	CbGpPWpGaD
Everolimus—MTOR—Disease—MTHFR—rheumatoid arthritis	8.95e-06	0.00016	CbGpPWpGaD
Everolimus—MTOR—Disease—HLA-A—rheumatoid arthritis	8.93e-06	0.00016	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—POMC—rheumatoid arthritis	8.92e-06	0.00016	CbGpPWpGaD
Everolimus—MTOR—Adaptive Immune System—NFKB1—rheumatoid arthritis	8.85e-06	0.000159	CbGpPWpGaD
Everolimus—MTOR—Immune System—TLR4—rheumatoid arthritis	8.84e-06	0.000158	CbGpPWpGaD
Everolimus—MTOR—Immune System—HLA-DRB1—rheumatoid arthritis	8.83e-06	0.000158	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—RASGRP1—rheumatoid arthritis	8.73e-06	0.000156	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CCL2—rheumatoid arthritis	8.72e-06	0.000156	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SYK—rheumatoid arthritis	8.7e-06	0.000156	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL6R—rheumatoid arthritis	8.7e-06	0.000156	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PRKCQ—rheumatoid arthritis	8.54e-06	0.000153	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL6ST—rheumatoid arthritis	8.48e-06	0.000152	CbGpPWpGaD
Everolimus—MTOR—Immune System—ICAM1—rheumatoid arthritis	8.48e-06	0.000152	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—STAT1—rheumatoid arthritis	8.39e-06	0.00015	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CXCL10—rheumatoid arthritis	8.27e-06	0.000148	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD80—rheumatoid arthritis	8.16e-06	0.000146	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TYK2—rheumatoid arthritis	7.92e-06	0.000142	CbGpPWpGaD
Everolimus—MTOR—Disease—IL6ST—rheumatoid arthritis	7.83e-06	0.00014	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NOS3—rheumatoid arthritis	7.77e-06	0.000139	CbGpPWpGaD
Everolimus—MTOR—Disease—NOS2—rheumatoid arthritis	7.77e-06	0.000139	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL6R—rheumatoid arthritis	7.57e-06	0.000136	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MMP3—rheumatoid arthritis	7.55e-06	0.000135	CbGpPWpGaD
Everolimus—MTOR—Disease—CD80—rheumatoid arthritis	7.54e-06	0.000135	CbGpPWpGaD
Everolimus—FKBP1A—Disease—TGFB1—rheumatoid arthritis	7.34e-06	0.000132	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	7.32e-06	0.000131	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—PTK2—rheumatoid arthritis	7.26e-06	0.00013	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCL5—rheumatoid arthritis	7.12e-06	0.000128	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	7.07e-06	0.000127	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CSF2—rheumatoid arthritis	7.01e-06	0.000126	CbGpPWpGaD
Everolimus—MTOR—Disease—IL6R—rheumatoid arthritis	6.98e-06	0.000125	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—CXCL8—rheumatoid arthritis	6.9e-06	0.000124	CbGpPWpGaD
Everolimus—MTOR—Immune System—TYK2—rheumatoid arthritis	6.89e-06	0.000123	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	6.65e-06	0.000119	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—SPP1—rheumatoid arthritis	6.6e-06	0.000118	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL2—rheumatoid arthritis	6.59e-06	0.000118	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	6.47e-06	0.000116	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—GC—rheumatoid arthritis	6.47e-06	0.000116	CbGpPWpGaD
Everolimus—MTOR—Immune System—IFNG—rheumatoid arthritis	6.45e-06	0.000116	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCR5—rheumatoid arthritis	6.42e-06	0.000115	CbGpPWpGaD
Everolimus—MTOR—Disease—TYK2—rheumatoid arthritis	6.36e-06	0.000114	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL2RA—rheumatoid arthritis	6.32e-06	0.000113	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—C3—rheumatoid arthritis	6.27e-06	0.000112	CbGpPWpGaD
Everolimus—MTOR—Disease—NOS3—rheumatoid arthritis	6.24e-06	0.000112	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MMP9—rheumatoid arthritis	6.24e-06	0.000112	CbGpPWpGaD
Everolimus—MTOR—Immune System—CD4—rheumatoid arthritis	6.23e-06	0.000112	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—NFKB1—rheumatoid arthritis	6.17e-06	0.000111	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—MAPK8—rheumatoid arthritis	6.07e-06	0.000109	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	6.01e-06	0.000108	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—LEP—rheumatoid arthritis	5.84e-06	0.000105	CbGpPWpGaD
Everolimus—MTOR—Innate Immune System—IL6—rheumatoid arthritis	5.79e-06	0.000104	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL1B—rheumatoid arthritis	5.75e-06	0.000103	CbGpPWpGaD
Everolimus—MTOR—Disease—CD4—rheumatoid arthritis	5.75e-06	0.000103	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL2—rheumatoid arthritis	5.73e-06	0.000103	CbGpPWpGaD
Everolimus—MTOR—Disease—PTGS2—rheumatoid arthritis	5.71e-06	0.000102	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—VEGFA—rheumatoid arthritis	5.6e-06	0.0001	CbGpPWpGaD
Everolimus—FKBP1A—Disease—IL6—rheumatoid arthritis	5.53e-06	9.91e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—FN1—rheumatoid arthritis	5.5e-06	9.86e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL6ST—rheumatoid arthritis	5.48e-06	9.82e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—NFKB1—rheumatoid arthritis	5.37e-06	9.62e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—MAPK8—rheumatoid arthritis	5.28e-06	9.46e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CD80—rheumatoid arthritis	5.28e-06	9.46e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MED1—rheumatoid arthritis	5.27e-06	9.45e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TGFB1—rheumatoid arthritis	5.14e-06	9.21e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—POMC—rheumatoid arthritis	5.01e-06	8.99e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CCL2—rheumatoid arthritis	4.91e-06	8.79e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	4.9e-06	8.78e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	4.9e-06	8.78e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL6R—rheumatoid arthritis	4.89e-06	8.77e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TYK2—rheumatoid arthritis	4.45e-06	7.98e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—BGN—rheumatoid arthritis	4.41e-06	7.91e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NOS3—rheumatoid arthritis	4.37e-06	7.84e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—TP53—rheumatoid arthritis	4.23e-06	7.58e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—TGFB1—rheumatoid arthritis	4.13e-06	7.4e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	4.06e-06	7.28e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—CXCL8—rheumatoid arthritis	3.88e-06	6.95e-05	CbGpPWpGaD
Everolimus—FKBP1A—Signaling Pathways—IL6—rheumatoid arthritis	3.87e-06	6.94e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL2—rheumatoid arthritis	3.71e-06	6.64e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MMP9—rheumatoid arthritis	3.51e-06	6.29e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—NFKB1—rheumatoid arthritis	3.47e-06	6.22e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—MAPK8—rheumatoid arthritis	3.41e-06	6.11e-05	CbGpPWpGaD
Everolimus—MTOR—Immune System—IL6—rheumatoid arthritis	3.37e-06	6.04e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	3.31e-06	5.93e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—VEGFA—rheumatoid arthritis	3.15e-06	5.65e-05	CbGpPWpGaD
Everolimus—MTOR—Disease—IL6—rheumatoid arthritis	3.11e-06	5.58e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TGFB1—rheumatoid arthritis	2.89e-06	5.18e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—CAT—rheumatoid arthritis	2.38e-06	4.27e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—TP53—rheumatoid arthritis	2.38e-06	4.27e-05	CbGpPWpGaD
Everolimus—MTOR—Signaling Pathways—IL6—rheumatoid arthritis	2.18e-06	3.9e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.99e-06	3.56e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—POMC—rheumatoid arthritis	1.59e-06	2.85e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—ALB—rheumatoid arthritis	1.45e-06	2.6e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	1.39e-06	2.49e-05	CbGpPWpGaD
Everolimus—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.27e-06	2.27e-05	CbGpPWpGaD
